FLUOROPHARMA MEDICAL, INC.
Profile
Company Names
FLUOROPHARMA MEDICAL, INC.
Addresses
8 HILLSIDE AVENUE, SUITE 108, MONTCLAIR, NJ 07042
8 HILLSIDE AVENUE, SUITE 207, MONTCLAIR, NJ 07042
500 BOYLSTON STREET, SUITE 1600, BOSTON, MA 02116
500 BOYLSTON STREET, SUITE 1600, BOSTON, MA 02116
Phone Numbers
973-744-1565
617-482-2333
6174822333
Entity Type:
CORPORATION
Industry:
PHARMACEUTICALS
Year Incorporated:
2007
State Incorporated:
NEVADA
Total Amount Raised:
$11,156,813.00
Number of Funding Rounds:
9
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
9
2016-03-23
$150,000.00
$1,000,000.00
$850,000.00
Debt
8
2015-05-28
$350,000.00
$2,000,000.00
$1,650,000.00
Debt
7
2014-07-22
$1,222,500.00
$2,000,000.00
$777,500.00
Debt
6
2013-12-31
$877,500.00
$2,000,000.00
$1,122,500.00
Equity
5
2013-09-18
$737,500.00
$7,000,000.00
$6,262,500.00
Equity, Debt
4
2013-06-21
$250,000.00
$500,000.00
$250,000.00
Debt
3
2012-11-19
$1,546,250.00
$4,000,000.00
$2,453,750.00
Equity
2
2011-06-23
$2,355,621.00
$6,000,000.00
$3,644,379.00
Equity
1
2011-05-16
$3,667,442.00
$6,000,000.00
$2,332,558.00
Equity
People
First Name
Middle Name
Last Name
Titles
Related Companies
DAVID
R.
ELMALEH
EXECUTIVE OFFICER, DIRECTOR
JOHAN (THIJS)
SPOOR
EXECUTIVE OFFICER, DIRECTOR
JOHAN (THIJS)
M.
SPOOR
EXECUTIVE OFFICER, DIRECTOR
WALTER
WITOSHKIN
DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
PHARMACEUTICALS
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Debt
2016-03-23
D
PHARMACEUTICALS
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Debt
2015-05-28
D
PHARMACEUTICALS
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Debt
2014-07-22
D
PHARMACEUTICALS
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2013-12-31
D
PHARMACEUTICALS
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity, Debt
2013-09-18
D
PHARMACEUTICALS
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Debt
2013-06-21
D
PHARMACEUTICALS
IN VITRO + IN VIVO DIAGNOSTIC SUBSTANCES [2835]
DECLINE TO DISCLOSE
Equity
2012-11-19
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#
